AU4433700A - Prolyl endopeptidase inhibitor - Google Patents

Prolyl endopeptidase inhibitor

Info

Publication number
AU4433700A
AU4433700A AU44337/00A AU4433700A AU4433700A AU 4433700 A AU4433700 A AU 4433700A AU 44337/00 A AU44337/00 A AU 44337/00A AU 4433700 A AU4433700 A AU 4433700A AU 4433700 A AU4433700 A AU 4433700A
Authority
AU
Australia
Prior art keywords
prolyl endopeptidase
endopeptidase inhibitor
inhibitor
prolyl
endopeptidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44337/00A
Inventor
Takeshi Inagaki
Hiroshi Kayahara
Kikuichi Tsukahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Domer Inc
Original Assignee
Domer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Domer Inc filed Critical Domer Inc
Publication of AU4433700A publication Critical patent/AU4433700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cereal-Derived Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU44337/00A 1999-05-19 2000-05-16 Prolyl endopeptidase inhibitor Abandoned AU4433700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/138791 1999-05-19
JP13879199A JP3148739B2 (en) 1999-05-19 1999-05-19 Prolyl endopeptidase inhibitor
PCT/JP2000/003135 WO2000071144A1 (en) 1999-05-19 2000-05-16 Prolyl endopeptidase inhibitor

Publications (1)

Publication Number Publication Date
AU4433700A true AU4433700A (en) 2000-12-12

Family

ID=15230311

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44337/00A Abandoned AU4433700A (en) 1999-05-19 2000-05-16 Prolyl endopeptidase inhibitor

Country Status (5)

Country Link
JP (1) JP3148739B2 (en)
KR (1) KR20020019442A (en)
CN (1) CN1361698A (en)
AU (1) AU4433700A (en)
WO (1) WO2000071144A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015804A1 (en) * 2001-08-17 2003-02-27 David Rudov Treatment to improve central nervous system function
KR20030068993A (en) * 2002-02-19 2003-08-25 박희원 A method for preparing stock compositions that can prevent and treat dementia and obesity.
EP1620091B1 (en) 2003-05-05 2010-03-31 Probiodrug AG Inhibitors of glutaminyl cyclase
NZ546887A (en) 2003-11-03 2009-04-30 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
KR101099206B1 (en) 2004-02-05 2011-12-27 프로비오드룩 아게 Novel Inhibitors of Glutaminyl Cyclase
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
WO2008065141A1 (en) 2006-11-30 2008-06-05 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
EP2865670B1 (en) 2007-04-18 2017-01-11 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
US20080260873A1 (en) * 2007-04-23 2008-10-23 Fancl Corporation Agent for prevention or improvement of neuropathy comprising pre-germinated brown rice lipid fraction as an effective ingredient
US8486940B2 (en) 2009-09-11 2013-07-16 Probiodrug Ag Inhibitors
JP6026284B2 (en) 2010-03-03 2016-11-16 プロビオドルグ エージー Inhibitors of glutaminyl cyclase
EP2545047B9 (en) 2010-03-10 2015-06-10 Probiodrug AG Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
KR101352396B1 (en) 2010-12-29 2014-01-17 전북대학교산학협력단 Composition for Treating or Preventing Brain Disease Comprising 1,3-dipalmitoyl-2-oleoylglycerol
JP6050264B2 (en) 2011-03-16 2016-12-21 プロビオドルグ エージー Benzimidazole derivatives as inhibitors of glutaminyl cyclase
CN105254498B (en) * 2014-07-18 2017-11-21 浙江康莱特药业有限公司 The glyceryl linoleate of 1,3 2 oleic acid of compound 2, preparation, preparation method and applications
PL3461819T3 (en) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitors of glutaminyl cyclase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3727383B2 (en) * 1995-07-31 2005-12-14 月桂冠株式会社 Prolyl endopeptidase inhibitor
JP3585592B2 (en) * 1995-07-31 2004-11-04 月桂冠株式会社 Oral intake
JP3880664B2 (en) * 1996-09-04 2007-02-14 月桂冠株式会社 Prolyl endopeptidase inhibitory peptide

Also Published As

Publication number Publication date
CN1361698A (en) 2002-07-31
WO2000071144A1 (en) 2000-11-30
KR20020019442A (en) 2002-03-12
JP3148739B2 (en) 2001-03-26
JP2000325042A (en) 2000-11-28

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
AU2002219555A1 (en) VLA-4 Inhibitors
GB9912961D0 (en) Metalloprotease inhibitors
AU4882101A (en) Mmp-12 inhibitors
AU6007200A (en) Cysteine protease inhibitors
AU4433700A (en) Prolyl endopeptidase inhibitor
AU4723799A (en) Protease inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU3074500A (en) Proteasome inhibitors
AU2001294557A1 (en) Thrombin inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
AU9059798A (en) Urokinase inhibitors
AU4092799A (en) Protease inhibitors
AUPP982399A0 (en) Mmp inhibitor
AU2002322802A1 (en) Thrombin inhibitors
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
AU9110298A (en) Protease inhibitors
AU2001220281A1 (en) Rollerboard for road-skiing
AU7126900A (en) Enzyme inhibitors
AU3235100A (en) Prothease inhibitors
AU1588901A (en) Protease inhibitors
AU1474801A (en) Protease inhibitors
AU2713100A (en) Protease inhibitors
AU4564499A (en) Protease inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase